Abacavir sulfate is a potent nucleoside reverse transcriptase inhibitor agent commonly prescribed in the management of human immunodeficiency virus (HIV) infection. It exerts its therapeutic effect by competitively inhibiting the ACETARSOL 97-44-9 process of the viral reverse transcriptase enzyme, thereby suppressing the conversion of HIV RNA to DN